(. (0022-3476 (1).The (10), (11). (12),it (12).Quite (14) (15). (16). (17-19). (18). (19) (2). (20). (2046-4924 (22, (24) (24). (25) (26-28) (29) (3). (3, (30). (4, (7). (7-12%) (8). (9) (? (CF). (CFRD) (Electronic)). (Lantus®) (Multiple (Print)). (this . 0 0.8% 1 1-50 10 10-20year 109. 10years 11.9% 12). 120 120minute 16 16(24). 1994;83(1):72-7. 2% 2-hour 20%(13) 2001;6(8):345-50. 2005;146(5):681-7. 2007; 2008. 2008;43(7):642-7. 2009;32:1626-31. 2010;11(7):487-92. 2010;33:2697-708. 2012 2012;Volume: 2014 2014;13(4):478-84. 2014;13(5):589-92. 2014;13:S23-S42. 2016;7(4):611-20. 23). 26% 30):395-6. 34 35% 5 5)The 50% 6 6.0% 60% 70% 75g A A, AA, AI, AM, AR, Abnormal Abnormalities Acta Adler Adolescents Adults. Age All Although American Approach Assessment B, BC, BG BMI BSF, Ballmann Basal Because Bell Best Bilton Bizzari Blood Bojcin Both British Brunzell Bryon Buono Burhan Butler C, C. CAR. CF CFRD CFRD, CFRD. CFRDT CGM CGM. CGMs CGM’s CONCLUSION: CRFD CS, CTFR Care Care. Care: Chamnan Children Clinical Cohen Cohort Compared Considerations Constantinescu Continuous Craigie Current Cystic D, D. DISCUSSION: Daily Danish Definition Derangements Despite Determinants Devices Diabetes Diabetes. Diabetes: Diabetologist Diagnosis Do Doherty Duff Dunitz E, Early Eichler Endocrinology Epidemiology Eur European Ewings F, FEV1 FEV1.This FJ, Fau Female Fibrosis Fibrosis-Related Fibrosis. Fibrosis–Related Flume Franzese Frohnert G, GC, Gauthier Genetic Gilchrist Glucose Guidelines H, Haworth HbA1C Health Ho Holme Hyperglycemia Hypoglycaemia Höfler I I, IGT(Impaired II If In Incidence, Indeterminate Injections) Insulin Insulin-Lantus® It J J, Jones Journal K, KL, Katz Kingdom. Koch L L, Laguna Lanng Leclercq Ledson Lenney Liou Lund-Andersen M, MDIs MDI’s MDT MI, MJ, MJ. Management Many Marshall McKenna Med Mellitus. Metabolism2008. Miller Mohan Monitoring Moran Moreau Morgan Mortality. Mozzillo N N, NIHR Nathan Nerup Novorapid® Now Nutritional OGTT OGTT(21). OGTT. Ode Onady One Oral Organization Our P P, Paediatrica. Pandit Pediatr Pediatric Pediatrics. Phillips Practical Practice Prevalence, Pulmonol Pulmonol. R, RC, RP, Raffeeq Random References Regelmann Related Relying Report Res. Results Rosenecker Rosner Royle S, SC, SM, Saeed Sainsbury Schiøtz Screening Sepe Several Shine Smaczny Smyth Society Some Spagnuolo Standards Steinkamp Stoddard Suppl. System T, TG, Technology Test The Therapy. There These They This Thomas Thorsteinsson Three Tolerance Tolerance) Trends Type UK United V V, Valerio W, W. WHO WHO/IDF WJ. Walshaw Wang Waugh We Weiss While Whitehouse Wickens-Mitchell With X X, a ability able abnormal abnormalities about absence according account acting actual added adolescence. adolescents adult adulthood advocate advocated affect after age age, age: agreement akin al. all almost alone, alongside already also an analysis. and annual another answer any approach appropriate are arresting article articles as assessing assessment assessments associated association at authors bar basal based be becoming been before beginning being below below. better between bigger blood blown burden burdensome but by can care carefully categories category centers. centre certain challenge change checks child children children. choose chosen chronic class classification clinical clinically clustered cohort cohort, collected combined commence commenced common compared complication complications, complications. condition confirmed consensus consent. considered consultant consultation2006. continued continuous contributory cope criteria crop current currently currently. curves). cystic dangers data deal decision decision. decisions decline delay demonstrated described detect detection deteriorating deterioration determine develop developing diabetes diabetes. diabetes: diabetic diabetics. diagnosed diagnosing diagnosis diagnosis. diagnostic differences different discharge discomforts disease distribution do dominance dose downside due during earlier early enabled ended endocrine enhanced enough equates et even eventually evidence exact except excluding excursions excursions, expectancy expensive, extend facility. fact fact, factor? families family fasting fasting-hyperglycaemia female female. females few fibrosis fibrosis-related fibrosis. fibrosis: figure figures first five follow followed following for found four frequent from full function future gain gene general give given, glucose gold growth guidelines guidelines. had hadn’t hard hardly has have having health help helpful. high higher homeostasis hopefully hour hours how hyperglycaemia hyperglycaemia. hyperglycaemias hyperglycemia hyperglycemia: hypoglycaemia hypoinsulinemic i.e. iceberg if illness immediately impact impairment improve improved improvement improves in incidence include included including increase increased increases incredibly individualised. inferior initially initiate initiation insidious insights instituting institution insulin insulin. intermediate interpreting intervals intervention. into involved involvement is isn’t it its just key known large late leads level levels levels. life life. light likely limited limits literature load long longitudinal loss loss, lung made manage managed, managing mark mastered may meals meals. mean measure(minute-120) measured median mellitus met metabolic metabolism methods minute-60 minutes(6) minutes. miss missed monitoring monitoring. months. more much multidisciplinary must mutations. native negative no no-brainer normal normally not now numbers nutritional occurs of off old older older, oldest old’s. on one one. only onset opposed or other our outcome. over overall overnight p. paediatric parameters patient patients patients). patients. patients: patient’s pediatric perhaps period’’ persists, phase phenomenon pick-up picked picture. played point poor population population. possible post-prandial postprandial preponderance prescribed presence present prevalence prevent previous previously processes production. professionally prompt protocol protocols. puberty pulmonary quality question question. quicker quite quoted raised random range ranged rapid rather reading received recommended recommends reduce reflects regime. regimen regular related relative relatively reliable remains report reported reports reports. represent research. resolved respiratory rest result resulted results retinopathy reversed reversing review review. reviewed reviews reviews. rise rises risk role routine same scope screened screening screening, see seeing self-defeating self-resolution series several severe sex sex, sex? shall shed short should showed shown significant silent, small smaller smallest so society some sometimes soon specialist spirometry spirometry. stable standard start started starting state state. stated status step, steroids still study study, subject such survey swings systematic table take tallied target taught team technique technology temporary term term. test test. testing tests, than that the their them then then, therapy therapy. there these these, they this those though, thus till times tip to tolerance too tool transient transiently treating treatment treatment. trial turn two unattractive under underestimated uniformity unit universal unreliable up use useful usual usually utility utility. variation varied very wait waiting was way we wearable weeks weight well were when whether which while who whole widespread will with without wondered worsening would year years yet you young – ‘’honeymoon ‘’when’’?